Correlation Between Telix Pharmaceuticals and Zentalis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telix Pharmaceuticals Limited and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Telix Pharmaceuticals and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Zentalis Pharmaceuticals.

Diversification Opportunities for Telix Pharmaceuticals and Zentalis Pharmaceuticals

0.36

Correlation Coefficient

Telix Pharmaceuticals  Zentalis Pharmaceuticals

Weak diversification

The 3 months correlation between Telix and Zentalis is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Zentalis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Zentalis Pharmaceuticals

Assuming the 90 days horizon Telix Pharmaceuticals Limited is expected to under-perform the Zentalis Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Telix Pharmaceuticals Limited is 2.26 times less risky than Zentalis Pharmaceuticals. The pink sheet trades about -0.24 of its potential returns per unit of risk. The Zentalis Pharmaceuticals Llc is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  350.00  in Zentalis Pharmaceuticals Llc on October 7, 2024 and sell it today you would lose (26.00) from holding Zentalis Pharmaceuticals Llc or give up 7.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.24%
Values	Daily Returns

Telix Pharmaceuticals Limited  vs.  Zentalis Pharmaceuticals Llc

Telix Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telix Pharmaceuticals Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Telix Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Zentalis Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Zentalis Pharmaceuticals Llc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Zentalis Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telix Pharmaceuticals and Zentalis Pharmaceuticals

The main advantage of trading using opposite Telix Pharmaceuticals and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.

The idea behind Telix Pharmaceuticals Limited and Zentalis Pharmaceuticals Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.